StockStory.org on MSN
RMD Q1 deep dive: Mask portfolio drives growth amid market uncertainty and new CFO appointment
Medical device company ResMed (NYSE:RMD) reported Q1 CY2026 results , with sales up 10.8% year on year to $1.43 billion. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results